KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.1400
+0.0500 (+4.59%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.0900
Open1.1300
Bid1.1500 x 0
Ask1.1600 x 0
Day's Range1.0500 - 1.1700
52 Week Range0.9400 - 4.3500
Volume447,895
Avg. Volume489,641
Market Cap129.856M
Beta (3Y Monthly)4.02
PE Ratio (TTM)N/A
EPS (TTM)-0.4100
Earnings DateMay 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • Baystreet

    Stocks in play: Khiron Life Sciences Corp.

    Recently participated in the Open Parliament held by Senate of Mexico on the theme of "Towards Cannabis ...

  • CNW Group

    Khiron Participates in Mexican Senate Cannabis Regulation Forum

    Mexico poised to become the largest market in the world to fully legalize cannabis nationwide Forum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico ...

  • CNW Group

    Khiron to Commercialize Kuida® Brand in U.K.

    Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® ...

  • CNW Group

    Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK

    TORONTO, Oct. 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019. Alvaro Torres, Khiron CEO and director will present at the conference, and Franziska Katterbach, Khiron Chief Legal Officer (Europe) will participate in a regulatory panel. The Company will also be available for pre-scheduled one-on-one meetings during the conference.

  • Those Who Purchased Khiron Life Sciences (CVE:KHRN) Shares A Year Ago Have A 29% Loss To Show For It
    Simply Wall St.

    Those Who Purchased Khiron Life Sciences (CVE:KHRN) Shares A Year Ago Have A 29% Loss To Show For It

    It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

  • CNW Group

    Khiron to Present and Host Attendees at First MJBizDaily Latin American Cannabis Symposium

    TORONTO, Sept. 26, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will sponsor and participate in MJBizDaily's first Latin American Cannabis Symposium taking place September 30 - October 1 in Bogotá, Colombia. Khiron will be featured prominently throughout the two-day symposium hosting networking events, showcases, and participating in panel presentations by key members of the Company's leadership team.

  • Khiron Secures Approval to Sell Three More CBD Wellness Products
    CNW Group

    Khiron Secures Approval to Sell Three More CBD Wellness Products

    TORONTO, Sept. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval from INVIMA, Colombia's health agency, to sell 3 additional Kuida® CBD skin care products. This expands on the 7 products currently available at retail and online in Colombia, with first sales of the newly approved product expected in Q4.

  • Newsfile

    Khiron CEO Alvaro Torres Talks Trailblazing in Colombia and Expanding Operations

    Toronto, Ontario--(Newsfile Corp. - September 18, 2019) - Capital 10X President Evan Veryard sits down with Khiron Life Sciences (TSXV: KHRN) CEO Alvaro Torres.They discuss Khiron's Colombian operations, expansion plans, and whether Khiron is on track to meet analyst expectations.Cannot view this video? Visit:https://capital10x.com/khiron-khrn-ceo-alvaro-torres-colombia-operations/For more information, please contact:Capital 10XEvan Veryard, President416-571-9037To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47907

  • CNW Group

    /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

    Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2019 /CNW/ - Virtual Investor Conferences and KCSA Strategic Communications today announced ...

  • Market Exclusive

    Khiron Believes Uruguay Cannabis Facility Will Strengthen Position in Latin America

    Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) has started construction of a cultivation and processing facility in Juan Lacaze, Uruguay. The 105,486-sq.-ft. state-of-the-art facility will have a production capacity of 17 tons per year and will help the company keep supplying regularly cannabis to key international markets, including Brazil and Europe. Uruguay Cannabis […]The post Khiron Believes Uruguay Cannabis Facility Will Strengthen Position in Latin America appeared first on Market Exclusive.

  • Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
    CNW Group

    Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity

    TORONTO, Sept. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that it has commenced construction of a 9,800 m2 (105,486 sq.ft) cultivation and processing facility in Juan Lacaze, Uruguay. With a production capacity of 17 tons per year, the Company's investment in this state-of-the-art facility represents a significant increase in Khiron's total production capacity, strengthening its ability to export and supply cannabis to key international markets, including Brazil and Europe.

  • Market Exclusive

    Cannabis Stock News Daily Roundup August 30

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company TerrAscend (CSE: TER) (OTCQX: TRSSF) has signed agreements to acquire ABI SF, which operates a Bay Area cannabis cultivation facility and owns the State Flower brand. State Flower is known for its ultra-premium cannabis flower and is currently sold through dispensaries in California and Nevada. Vapen […]The post Cannabis Stock News Daily Roundup August 30 appeared first on Market Exclusive.

  • CNW Group

    Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics

    Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado ) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression ...

  • 2 Top Colombian Pot Stocks to Buy Today
    The Motley Fool

    2 Top Colombian Pot Stocks to Buy Today

    Avicanna Inc. (TSXV:AVCN) and Khiron Life Sciences Corp. (TSX:KHRN) are attractively valued and poised to soar.

  • CNW Group

    Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results

    Expands distribution for Kuida cosmeceutical brand, signing distribution agreements with Fedco, Linio, Cafam – large consumer distribution channels in Colombia. Subsequent to the quarter signed distribution agreement with Grupo Exito, one of South America's market leading retail groups. Completed construction and commenced operations of cultivation, extraction, and analysis facilities near Ibague, Colombia.

  • Market Exclusive

    Khiron Creates ‘Sophisticated’ Medical Cannabis Facility in Latin America

    Khiron Life Sciences (OTCQB:KHRNF) has issued an update on its cultivation and production operations in Colombia. The company said that it has achieved significantly expanded analysis, extraction and purification capabilities across its cultivation facility near Ibague. Khiron claims that it owns and operates one of the "most sophisticated" medical cannabis cultivation and processing facilities in Latin America. […]The post Khiron Creates 'Sophisticated' Medical Cannabis Facility in Latin America appeared first on Market Exclusive.

  • CNW Group

    Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities

    State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ...

  • Market Exclusive

    Cannabis Stock News Daily Roundup August 21

    Cannabis provider Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) announced the sale of certain of its assets in Florida and substantially all of its assets in Ohio. The company is selling 36 acres of land, comprising its Chestnut Hill Tree Farm site in Alachua County, Florida, as well as all of its assets in Ohio, […]The post Cannabis Stock News Daily Roundup August 21 appeared first on Market Exclusive.

  • How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio
    Simply Wall St.

    How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio

    I've been keeping an eye on Khiron Life Sciences Corp. (CVE:KHRN) because I'm attracted to its fundamentals. Looking...

  • CNW Group

    Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors

    TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.

  • CNW Group

    Khiron Provides Clarification of August 12, 2019 News Release

    TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.

  • CNW Group

    Khiron Boosts European Expansion With Key Executive Appointments

    Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...

  • CNW Group

    Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider

    Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate ...

  • Baystreet

    Heightened Interest in Hemp-Infused Beauty Products as Large Conglomerates Enter Space

    As the wave of positive reviews roll in, hemp-infused beauty products containing the non-psychoactive ...